Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence
- PMID: 19968401
- PMCID: PMC3742373
- DOI: 10.1037/a0017797
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence
Erratum in
- Exp Clin Psychopharmacol. 2010 Jun;18(3):296
Abstract
Reactivity to smoking-related cues may play a role in the maintenance of smoking behavior and may change depending on smoking status. Whether smoking cue-related functional MRI (fMRI) reactivity differs between active smoking and extended smoking abstinence states currently is unknown. We used fMRI to measure brain reactivity in response to smoking-related versus neutral images in 13 tobacco-dependent subjects before a smoking cessation attempt and again during extended smoking abstinence (52 +/- 11 days) aided by nicotine replacement therapy. Prequit smoking cue induced fMRI activity patterns paralleled those reported in prior smoking cue reactivity fMRI studies. Greater fMRI activity was detected during extended smoking abstinence than during the pre-quit [corrected] assessment subcortically in the caudate nucleus and cortically in prefrontal (BA 6, 8, 9, 10, 44, 46), [corrected] primary somatosensory (BA 1, 2, 3), temporal (BA 22), [corrected] parietal (BA 5, 7, 40), occipital (BA 17, 18), [corrected] and posterior cingulate (BA 31) cortex. These data suggest that during extended smoking abstinence, fMRI reactivity to smoking versus neutral stimuli persists in brain areas involved in attention, somatosensory processing, motor planning, and conditioned cue responding. In some brain regions, fMRI smoking cue reactivity is increased during extended smoking abstinence in comparison to the prequit state, which may contribute to persisting relapse vulnerability.
Figures
References
-
- Apicella P, Scarnati E, Ljungberg T, Schultz W. Neuronal activity in monkey striatum related to the expectation of predictable environmental events. Journal of Neurophysiology. 1992;68(3):945–960. - PubMed
-
- Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics. 2008;83(4):531–541. - PubMed
-
- Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, et al. Cue dependency of nicotine self-administration and smoking. Pharmacology, Biochemistry, and Behavior. 2001;70(4):515–530. - PubMed
-
- CDC. Press Release: Smoking Deaths Cost Nation $92 Billion in Lost Productivity Annually. 2005 Retrieved December, 2008, from http://www.cdc.gov/od/oc/media/pressrel/r050630.htm.
Publication types
MeSH terms
Substances
Grants and funding
- R01DA014674/DA/NIDA NIH HHS/United States
- R01 DA009448/DA/NIDA NIH HHS/United States
- K02DA017324/DA/NIDA NIH HHS/United States
- K02 DA017324/DA/NIDA NIH HHS/United States
- R01 DA014674/DA/NIDA NIH HHS/United States
- T32DA015036/DA/NIDA NIH HHS/United States
- K24DA015116/DA/NIDA NIH HHS/United States
- U01 DA019378/DA/NIDA NIH HHS/United States
- T32 DA015036/DA/NIDA NIH HHS/United States
- U01DA019378/DA/NIDA NIH HHS/United States
- K24 DA015116/DA/NIDA NIH HHS/United States
- R01DA09448/DA/NIDA NIH HHS/United States
- R01DA022276/DA/NIDA NIH HHS/United States
- R01 DA022276/DA/NIDA NIH HHS/United States
